Cargando…

OCT4, SOX2, and NANOG positive expression correlates with poor differentiation, advanced disease stages, and worse overall survival in HER2(+) breast cancer patients

OBJECTIVE: This study aimed to evaluate the correlations of expression of OCT4, SOX2, and NANOG with clinicopathological features and overall survival (OS) in human epidermal growth factor receptor 2-positive (HER2(+)) breast cancer (BC) patients. METHODS: One hundred and thirty-four surgical HER2(+...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Fan, Zhang, Jiaming, Yang, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6228048/ https://www.ncbi.nlm.nih.gov/pubmed/30464534 http://dx.doi.org/10.2147/OTT.S173522

Ejemplares similares

Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma
por: Martins Balbinot, Karolyny, et al.
Publicado: (2023)

SUMOylation Represses Nanog Expression via Modulating Transcription Factors Oct4 and Sox2
por: Wu, Yongyan, et al.
Publicado: (2012)

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
por: Robinson, Mikella, et al.
Publicado: (2021)

The effects of embryo splitting on Cdx2, Sox2, Oct4, and Nanog gene expression in mouse blastocysts
por: Rahbaran, M., et al.
Publicado: (2022)

SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis
por: Swain, Niharika, et al.
Publicado: (2020)

High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma
por: Knipper, Karl, et al.
Publicado: (2023)

Geminin Escapes Degradation in G1 of Mouse Pluripotent Cells and Mediates the Expression of Oct4, Sox2, and Nanog
por: Yang, Valerie S., et al.
Publicado: (2011)

Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
por: Pedregal-Mallo, Daniel, et al.
Publicado: (2020)

Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2013)

Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions
por: Xiao, Li, et al.
Publicado: (2017)

Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells
por: Carlin, Ryan, et al.
Publicado: (2006)

Correction: Embryonic Stem Cells Markers SOX2, OCT4 and Nanog Expression and Their Correlations with Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2013)

Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer
por: You, Liuping, et al.
Publicado: (2018)

Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors
por: Amaya, Clarissa N., et al.
Publicado: (2015)

Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue
por: Baghai Naini, Fereshteh, et al.
Publicado: (2019)

CKAP2 overexpression correlates with worse overall survival in patients with lung adenocarcinoma
por: Zhang, Sen, et al.
Publicado: (2022)

The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer
por: Sodja, Eva, et al.
Publicado: (2016)

SOX2 Is Regulated Differently from NANOG and OCT4 in Human Embryonic Stem Cells during Early Differentiation Initiated with Sodium Butyrate
por: Kallas, Ade, et al.
Publicado: (2014)

Bright/Arid3A Acts as a Barrier to Somatic Cell Reprogramming through Direct Regulation of Oct4, Sox2, and Nanog
por: Popowski, Melissa, et al.
Publicado: (2014)

Identification and characterisation of NANOG+/ OCT-4(high)/SOX2+ doxorubicin-resistant stem-like cells from transformed trophoblastic cell lines
por: Balahmar, Reham M., et al.
Publicado: (2018)

Evaluation of the Effect of Orlistatorlistat on Expression of OCT4, Nanog, SOX2, and KLF4 Genes in Colorectal Cancer SW40 Cell Line
por: Noroozi Karimabad, Mojgan, et al.
Publicado: (2021)

Structural mechanism of DNA-mediated Nanog–Sox2 cooperative interaction
por: Yesudhas, Dhanusha, et al.
Publicado: (2019)

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer
por: Hosonaga, Mari, et al.
Publicado: (2018)

293FT cells transduced with four transcription factors (OCT4, SOX2, NANOG, and LIN28) generate aberrant ES-like cells
por: Oka, Y, et al.
Publicado: (2010)

Changes in the methylation status of the Oct3/4, Nanog, and Sox2 promoters in stem cells during regeneration of rat tracheal epithelium after injury
por: Zhou, Ying, et al.
Publicado: (2016)

Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells
por: Kallas, Ade, et al.
Publicado: (2014)

CD24 and Nanog expression in Stem Cells in Glioblastoma: Correlation with Response to Chemoradiation and Overall Survival
por: Soni, Priyanka, et al.
Publicado: (2017)

HIF-2α Regulates NANOG Expression in Human Embryonic Stem Cells following Hypoxia and Reoxygenation through the Interaction with an Oct-Sox Cis Regulatory Element
por: Petruzzelli, Raffaella, et al.
Publicado: (2014)

Two-stage induced differentiation of OCT4(+)/Nanog(+) stem-like cells in lung adenocarcinoma
por: Li, Rong, et al.
Publicado: (2016)

Nanog, Oct4 and Tet1 interplay in establishing pluripotency
por: Olariu, Victor, et al.
Publicado: (2016)

High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019)

Increased Levels of Circulating and Tissue mRNAs of Oct-4, Sox-2, Bmi-1 and Nanog is ESCC Patients: Potential Tool for Minimally Invasive Cancer Diagnosis
por: Bahl, Kriti, et al.
Publicado: (2012)

Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control embryonic stem (ES) cell fate determination
por: Johansson, Helena, et al.
Publicado: (2010)

Increased expression of stemness genes REX-1, OCT-4, NANOG, and SOX-2 in women with ovarian endometriosis versus normal endometrium: A case-control study
por: Shariati, Fatameh, et al.
Publicado: (2019)

Culture of leukocyte-derived cells from human peripheral blood: Increased expression of pluripotent genes OCT4, NANOG, SOX2, self-renewal gene TERT and plasticity
por: Lee, Yi-Jen, et al.
Publicado: (2023)

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018)

The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review
por: Mendes, Diogo, et al.
Publicado: (2015)

Anti-HER2 antibody prolongs overall survival disproportionally more than progression-free survival in HER2-Positive metastatic breast cancer patients
por: Chen, I-Chun, et al.
Publicado: (2021)

Pyrotinib plus capecitabine could significantly improve overall survival in HER2-positive metastatic breast cancer
por: Guan, Xiuwen, et al.
Publicado: (2023)

HER2 exon 27 mutations predict worse survival of breast cancer patients, especially in HER2‐negative patients
por: Si, Pilei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_otf9h999a32oua6vbclfcitkun